Find an MSK Doctor or Cancer Specialist
Memorial Sloan Kettering interventional pulmonologist Or Kalchiem-Dekel

Or Kalchiem-Dekel, MD

Interventional Pulmonologist

My Role at MSK

Areas of Expertise

My Specialties

  • Lung Nodules
  • Robotic Bronchoscopy
  • Endobronchial Ultrasound (EBUS)
View all
Dr. Kalchiem-Dekel's Office Information
Languages: English & Hebrew

Request an Appointment

Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.
Back to top
English
Share

About Me

What I Do at MSK
  • Assistant Attending
Get To Know Me

I am an interventional pulmonologist specializing in minimally invasive procedures to diagnose and treat cancers and other ailments involving the chest, such as lung complications related to cancer treatment. This includes:

  • Bronchoscopy procedures using a robotic, flexible, or rigid bronchoscope
  • Procedures to diagnose and treat pleural effusions (the buildup of fluid between the tissue that lines the lung and chest cavity), such as pleuroscopy, placement of pleural catheters, and chemical pleurodesis.

My special interest and research focus is in the field of robotic-assisted bronchoscopy. I am interested in using this innovative technology to develop and implement new ways to effectively and safely biopsy and treat cancerous lung lesions.

My Role at MSK

An interventional pulmonologist (IN-ter-VEN-shun-al pull-muh-NAHL-uh-jist) is a doctor with special training in treating lung problems, such as blocked airways, cancer, and tumors.

Areas of Expertise

My Specialties

  • Lung Nodules
  • Robotic Bronchoscopy
  • Endobronchial Ultrasound (EBUS)
  • Airway Tumor Ablation
  • Airway Stents
  • Endobronchial Valves
  • Pleural Effusion Management
  • Pleuroscopy
  • Percutaneous Tracheostomy
Education & Honors

Education

  • MD, Ben-Gurion University of the Negev, Israel

Residencies

  • Internal Medicine - Soroka University Medical Center, Israel

Awards and Honors

  • Award Recipient, Annual Respiratory Young Investigators’ Forum (2019)
  • Best Basic Science Research Award Recipient, Metropolitan DC Thoracic Society Annual Meeting (2019)
  • Award Recipient, American College of Chest Physicians Asthma Fellows Conference (2017)

Fellowships

  • Pulmonary and Critical Care Medicine, University of Maryland Medical Center, Baltimore, MD
  • Advanced Pulmonary and Critical Care Medicine - Academic Research Track, National Institutes of Health, Bethesda, MD
  • Interventional Pulmonology - Memorial Sloan Kettering Cancer Center

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Aetna

In Network Coverage Type
HMO, EPO PPO, POS, Transplant

Aetna Medicare Advantage (MTA and NYC retirees only)

In Network Coverage Type
PPO

Anthem BCBS and other BCBS licensee plans

In Network Coverage Type
PPO, POS, EPO, HMO

See updates

Anthem BCBS Health Plus

In Network Coverage Type
HMO

See updates

Anthem Blue Cross Medicare Advantage

In Network Coverage Type
PPO, HMO, DSN

See updates

Blue Cross Blue Shield Federal Employee Program

In Network Coverage Type
HMO, PPO

See updates

Blue Cross Blue Shield states outside of NY/NJ

In Network Coverage Type
HMO, EPO PPO, POS

See updates

Carrum Health

In Network Coverage Type
Supplemental

Cigna

In Network Coverage Type
PPO, POS, HMO

Connecticare

In Network Coverage Type
POS, EPO, HMO

Emblem

In Network Coverage Type
PPO, POS, EPO, HMO

Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.

Emblem Essential

In Network Coverage Type
HMO

Emblem Medicare Advantage (Medicare Choice PPO Network and VIP Prime Network Only)

In Network Coverage Type
PPO, HMO

Empire Essential

In Network Coverage Type
HMO

Empire Plan / NYSHIP (Blue Cross/UnitedHealthcare split plan)

In Network Coverage Type
PPO

See updates

Fidelis

In Network Coverage Type
HMO, EPO

Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.

Fidelis Managed Medicaid & HARP

In Network Coverage Type
HMO

Fidelis Medicare Advantage

In Network Coverage Type
HMO

First Health

In Network Coverage Type
PPO

Healthfirst

In Network Coverage Type
EPO, HMO, PPO, POS

Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.

Healthfirst Managed Medicaid

In Network Coverage Type
HMO

Healthfirst Medicare Advantage

In Network Coverage Type
HMO, PPO

Healthsmart

In Network Coverage Type
PPO EPO

Horizon Blue Cross Blue Shield New Jersey (HMO)

In Network Coverage Type
HMO

See updates

Horizon Blue Cross Blue Shield New Jersey (PPO)

In Network Coverage Type
PPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier I (EPO)

In Network Coverage Type
EPO

See updates

Horizon Blue Cross Blue Shield New Jersey Omnia Tier II (EPO)

In Network Coverage Type
EPO

See updates

Horizon Medicare Advantage

In Network Coverage Type
PPO, HMO

Husky CT Medicaid

In Network Coverage Type
State Government

Magnacare

In Network Coverage Type
PPO, POS, EPO

Straight NJ Medicaid

In Network Coverage Type
State Government

Straight NY Medicaid

In Network Coverage Type
State Government

Medicare Part A&B (traditional Medicare)

In Network Coverage Type
Federal Government

Multiplan/Beech Street/PHCS

In Network Coverage Type
Supplemental

MVP

In Network Coverage Type
PPO/OAP

Non-Participating Plans with Out of Network Benefits

In Network Coverage Type
PPO, POS, EPO, HMO

NYC Medicare Advantage Plus for City Employees

In Network Coverage Type
TBD

Oscar

In Network Coverage Type
HMO/EPO

Oxford

In Network Coverage Type
PPO, EPO

World Trade Center Health Program (WTC)

In Network Coverage Type
State Government

Qualcare

In Network Coverage Type
PPO, POS, HMO

Tricare

In Network Coverage Type
PPO, HMO

UMR

In Network Coverage Type
PPO, POS

United Healthcare

In Network Coverage Type
PPO, POS, HMO

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking

New Patients

Scheduling an appointment is easy. Click or call 212-639-5061— we’re available 24 hours a day, 7 days a week
Make an Appointment

Current Patients

Request an appointment by logging on to MyMSK or calling your doctor’s office. If you aren’t registered for MyMSK, call 646-227-2593 for your Enrollment ID.

Contact and Location

Dr. Kalchiem-Dekel sees patients at two locations.

Office Phone
Location
New York, NY
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
530 East 74th Street New York NY 10021
Get Directions
Memorial Sloan Kettering Cancer Center
1275 York Avenue New York NY 10065
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Critical Care Medicine Service doctors

See all Pulmonary Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Kalchiem-Dekel O, Tran BC, Glick DR, Ha NT, Iacono A, Pickering EM, Shah NG, Sperry MG, Sachdeva A, Reed RM. Prophylactic epinephrine attenuates severe bleeding in lung transplantation patients undergoing transbronchial lung biopsy: Results of the PROPHET randomized trial. J Heart Lung Transplant. 2023 Sep;42(9):1205-1213. doi: 10.1016/j.healun.2023.03.007. Epub 2023 Mar 14.PMID: 37140517 Clinical Trial.

Kalchiem-Dekel O, Falcon CJ, Bestvina CM, Liu D, Kaplanis LA, Wilhelm C, Eichholz J, Harada G, Wirth LJ, Digumarthy SR, Lee RP, Kadosh D, Mendelsohn RB, Donington J, Gainor JF, Drilon A, Lin JJ. Chylothorax and Chylous Ascites During RET Tyrosine Kinase Inhibitor Therapy. J Thorac Oncol. 2022 Jul 1:S1556-0864(22)00312-4. doi: 10.1016/j.jtho.2022.06.008. Online ahead of print. PMID: 35788405

​​​​Kalchiem-Dekel O, Connolly JG, Lin IH, Husta BC, Adusumilli PS, Beattie JA, Buonocore DJ, Dycoco J, Fuentes P, Jones DR, Lee RP, Park BJ, Rocco G, Chawla M, Bott MJ. Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions. Chest. 2021 Aug 9:S0012-3692(21)03625-4. doi: 10.1016/j.chest.2021.07.2169. Online ahead of print.PMID: 34384789

Read more

Kalchiem-Dekel O, Fuentes P, Bott MJ, Beattie JA, Lee RP, Chawla M, Husta BC. Multiplanar 3D fluoroscopy redefines tool-lesion relationship during robotic-assisted bronchoscopy. Respirology. 2021 Jan;26(1):120-123. doi: 10.1111/resp.13966. Epub 2020 Nov 2.PMID: 33140495

Kalchiem-Dekel O, Schwalk AJ, Patel NM, Lin IH, Beattie JA, Husta BC, Chawla M, Sachdeva A, Akulian JA, Musani AI, Argento AC, Lee HJ, Mullon JJ, Desai NR, Hsia DW, Lee RP. COVID-19 Impact on Interventional Pulmonology Training.  ATS Sch. 2021 Apr 13;2(2):236-248. doi: 10.34197/ats-scholar.2020-0126OC. eCollection 2021 Jun.PMID: 34409418

Kalchiem-Dekel O, Yao X, Barochia AV, Kaler M, Figueroa DM, Karkowsky WB, Gordon EM, Gao M, Fergusson MM, Qu X, Liu P, Li Y, Seifuddin F, Pirooznia M, Levine SJ. Apolipoprotein E Signals via TLR4 to Induce CXCL5 Secretion by Asthmatic Airway Epithelial Cells. Am J Respir Cell Mol Biol. 2020 Aug;63(2):185-197. doi: 10.1165/rcmb.2019-0209OC. PMID: 32338995; PMCID: PMC7397770.

Kalchiem-Dekel O, Hines SE. Forty years of reference values for respiratory system impedance in adults: 1977-2017. Respir Med. 2018 Mar;136:37-47. doi: 10.1016/j.rmed.2018.01.015. Epub 2018 Jan 31. PMID: 29501245.

Kalchiem-Dekel O, Yao X, Levine SJ. Meeting the Challenge of Identifying New Treatments for Type 2-Low Neutrophilic Asthma. Chest. 2020 Jan;157(1):26-33. doi: 10.1016/j.chest.2019.08.2192. Epub 2019 Sep 13. PMID: 31525357; PMCID: PMC6965689.

Kalchiem-Dekel O, Iacono A, Pickering EM, Sachdeva A, Shah NG, Sperry M, Tran BC, Reed RM. Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial. BMJ Open. 2019 Mar 23;9(3):e024521. doi: 10.1136/bmjopen-2018-024521. PMID: 30904852; PMCID: PMC6475255.

Kalchiem-Dekel O, Iacono A, Pickering EM, Sachdeva A, Shah NG, Sperry M, Tran BC, Reed RM. Prophylactic epinephrine for the prevention of transbronchial lung biopsy-related bleeding in lung transplant recipients (PROPHET) study: a protocol for a multicentre randomised, double-blind, placebo-controlled trial. BMJ Open. 2019 Mar 23;9(3):e024521. doi: 10.1136/bmjopen-2018-024521. PMID: 30904852; PMCID: PMC6475255.

Kalchiem-Dekel O, Shanholtz CB, Jeudy J, Sachdeva A, Pickering EM. Feasibility, safety, and utility of bronchoscopy in patients with ARDS while in the prone position. Crit Care. 2018 Mar 2;22(1):54. doi: 10.1186/s13054-018-1983-3. PMID: 29499729; PMCID: PMC5834861.

Gavish R, Levy A, Dekel OK, Karp E, Maimon N. The Association Between Hospital Readmission and Pulmonologist Follow-up Visits in Patients With COPD. Chest. 2015 Aug;148(2):375-381. doi: 10.1378/chest.14-1453. PMID: 25611698.

Avnon L, Kalchiem-Dekel O, Gozlan-Talmor A, Shimonovitch F, Shalev R, Maimon N. [THE ROLE OF CLOSED PLEURAL BIOPSY IN THE DIAGNOSIS OF TUBERCULOUS PLEURISY IN A POPULATION AT-RISK]. Harefuah. 2016 Feb;155(2):110-4, 130-1. Hebrew. PMID: 27215124.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Or Kalchiem-Dekel discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.


View all disclosures